This case highlights the importance of considering BRASH syndrome as a clinical entity in at-risk populations, namely polymedicated elderly patients, especially in light of the synergistic combination of bradycardia, renal insufficiency, the use of renin-angiotensin system blockers, and hyperkalemia. The gene discussed is REN; the disease is Bradycardia.